SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GLAXO (GLX)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Keith Fauci who wrote ()2/23/1998 11:00:00 PM
From: Barron Von Hymen  Read Replies (3) of 222
 
Time to pay the reaper. GLX showed 7% decline in sales in last earnings report just under a week ago. With GLX trading at around $48 prior to ticking up to $65+ on merger announcement, I bet GLX will open up tomorrow around $45 or so and bleed down for the next few months, since there's still positive analysts comments built into the stock price based on the event of a merger. There'll be a lot of p@#$$'d off investors. I dare predict a target of $40 before the month is through. The prudent value investor would be interested of these shares near $40. I am talking about the ADR's on NewYork.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News